» Articles » PMID: 22069696

Anthrax Lethal Toxin-mediated Disruption of Endothelial VE-cadherin is Attenuated by Inhibition of the Rho-associated Kinase Pathway

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2011 Nov 10
PMID 22069696
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic anthrax disease is characterized by vascular leakage pathologies. We previously reported that anthrax lethal toxin (LT) induces human endothelial barrier dysfunction in a cell death-independent manner with actin stress fiber formation and disruption of adherens junctions (AJs). In the present study, we further characterize the molecular changes in the AJ complex and investigate whether AJ structure and barrier function can be preserved by modulating key cytoskeletal signaling pathways. Here, we show that LT reduces total VE-cadherin protein and gene expression but the expression of the key linker protein beta-catenin remained unchanged. The changes in VE-cadherin expression correlated temporally with the appearance of actin stress fibers and a two-fold increase in phosphorylation of the stress fiber-associated protein myosin light chain (p-MLC) and cleavage of Rho-associated kinase-1 (ROCK-1). Co-treatment with ROCK inhibitors (H-1152 and Y27632), but not an inhibitor of MLC kinase (ML-7), blocked LT-induced p-MLC enhancement and stress fiber formation. This was accompanied by the restoration of VE-cadherin expression and membrane localization, and attenuation of the LT-induced increase in monolayer permeability to albumin. Together, these findings suggest the ROCK pathway may be a relevant target for countering LT-mediated endothelial barrier dysfunction.

Citing Articles

Anthrax lethal toxin exerts potent metabolic inhibition of the cardiovascular system.

Liu J, Zuo Z, Fattah R, Finkel T, Leppla S, Liu S mBio. 2024; 15(12):e0216024.

PMID: 39508614 PMC: 11633152. DOI: 10.1128/mbio.02160-24.


Cadmium exposure enhances VE-cadherin expression in endothelial cells via suppression of ROCK signaling.

Li X, Li X, Sun R, Gao M, Wang H Exp Ther Med. 2022; 23(5):355.

PMID: 35481222 PMC: 9016791. DOI: 10.3892/etm.2022.11282.


Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell.

Zhao M, Jiang H, Sun J, Wang Z, Hu B, Zhu C Front Immunol. 2021; 12:697071.

PMID: 34745088 PMC: 8564108. DOI: 10.3389/fimmu.2021.697071.


lethal toxin, but not edema toxin, increases pulmonary artery pressure and permeability in isolated perfused rat lungs.

Cui X, Xu W, Neupane P, Weiser-Schlesinger A, Weng R, Pockros B Am J Physiol Heart Circ Physiol. 2019; 316(5):H1076-H1090.

PMID: 30767685 PMC: 6580392. DOI: 10.1152/ajpheart.00685.2018.


Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis.

Liu J, Wada Y, Katsura M, Tozawa H, Erwin N, Kapron C Theranostics. 2019; 8(21):6053-6069.

PMID: 30613282 PMC: 6299434. DOI: 10.7150/thno.30305.


References
1.
Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J . Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol. 2001; 3(4):346-52. DOI: 10.1038/35070019. View

2.
Bogatcheva N, Verin A . The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res. 2008; 76(3):202-7. PMC: 2586393. DOI: 10.1016/j.mvr.2008.06.003. View

3.
Bhadriraju K, Elliott J, Nguyen M, Plant A . Quantifying myosin light chain phosphorylation in single adherent cells with automated fluorescence microscopy. BMC Cell Biol. 2007; 8:43. PMC: 2213650. DOI: 10.1186/1471-2121-8-43. View

4.
Cui X, Moayeri M, Li Y, Li X, Haley M, Fitz Y . Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol. 2004; 286(4):R699-709. DOI: 10.1152/ajpregu.00593.2003. View

5.
Yao L, Romero M, Toque H, Yang G, Caldwell R, Caldwell R . The role of RhoA/Rho kinase pathway in endothelial dysfunction. J Cardiovasc Dis Res. 2011; 1(4):165-70. PMC: 3023892. DOI: 10.4103/0975-3583.74258. View